-transparent.png){kind=logo}
Over 7 million cases of traveler's diarrhea, defined as the passage of > or = 3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominantly caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler's diarrhea.
Related Publications
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
July 2007,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
November 1994,
Antimicrobial agents and chemotherapy,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
July 2008,
The Medical letter on drugs and therapeutics,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
July 1982,
Schweizerische medizinische Wochenschrift,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
October 2021,
Deutsche medizinische Wochenschrift (1946),
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
July 1982,
The Western journal of medicine,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
September 2012,
Infectious disease clinics of North America,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
July 2019,
Canadian family physician Medecin de famille canadien,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
September 1993,
Gastroenterology clinics of North America,
J A Adachi, and
L Ostrosky-Zeichner, and
H L DuPont, and
C D Ericsson
July 1999,
Medizinische Monatsschrift fur Pharmazeuten,
